Cyclerion Therapeutics (CYCN) announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology, securing … Cyclerion Therapeutics (CYCN) announced that it ...
Cyclerion Therapeutics (CYCN) announced that it has entered into a licensing agreement with the Massachusetts Institute of Technology, securing … Cyclerion Therapeutics (CYCN) announced that it ...
DUBLIN and CHICAGO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a company focused on delivering next generation… DUBLIN and CHICAGO, Sept. 19, 2025 (...
DUBLIN and CHICAGO, Sept. 19, 2025 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), a company focused on delivering next generation… DUBLIN and CHICAGO, Sept. 19, 2025 (...
NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick… NEW ORLEANS, Sept. 18, 2025 (GLOBE...
NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick… NEW ORLEANS, Sept. 18, 2025 (GLOBE...
NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick… NEW ORLEANS, Sept. 18, 2025 (GLOBE...
